Login / Signup

Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts.

Seng Chan YouSungjae JungJoel N SwerdelPatrick B RyanMartijn J SchuemieMarc A SuchardSeongwon LeeJaehyeong ChoGeorge HripcsakRae Woong ParkChan Joo Lee
Published in: Korean circulation journal (2019)
There was no significant difference in mortality among A+C, A+D, and C+D combination treatment in patients without previous CVD. This finding was consistent across multi-national heterogeneous cohorts in real-world practice.
Keyphrases
  • quality improvement
  • blood pressure
  • primary care
  • healthcare
  • cardiovascular events
  • risk factors
  • type diabetes
  • coronary artery disease
  • clinical evaluation